142 related articles for article (PubMed ID: 26614654)
1. Quantitative analysis of drug effects at the whole-body level: a case study for glucose metabolism in malaria patients.
Snoep JL; Green K; Eicher J; Palm DC; Penkler G; du Toit F; Walters N; Burger R; Westerhoff HV; van Niekerk DD
Biochem Soc Trans; 2015 Dec; 43(6):1157-63. PubMed ID: 26614654
[TBL] [Abstract][Full Text] [Related]
2. A detailed kinetic model of glycolysis in Plasmodium falciparum-infected red blood cells for antimalarial drug target identification.
van Niekerk DD; du Toit F; Green K; Palm D; Snoep JL
J Biol Chem; 2023 Sep; 299(9):105111. PubMed ID: 37517694
[TBL] [Abstract][Full Text] [Related]
3. In silico multiple-targets identification for heme detoxification in the human malaria parasite Plasmodium falciparum.
Phaiphinit S; Pattaradilokrat S; Lursinsap C; Plaimas K
Infect Genet Evol; 2016 Jan; 37():237-44. PubMed ID: 26626103
[TBL] [Abstract][Full Text] [Related]
4. Targeting ion channels of Plasmodium falciparum-infected human erythrocytes for antimalarial development.
Desai SA
Curr Drug Targets Infect Disord; 2004 Mar; 4(1):79-86. PubMed ID: 15032636
[TBL] [Abstract][Full Text] [Related]
5. Modeling metabolism and stage-specific growth of Plasmodium falciparum HB3 during the intraerythrocytic developmental cycle.
Fang X; Reifman J; Wallqvist A
Mol Biosyst; 2014 Oct; 10(10):2526-37. PubMed ID: 25001103
[TBL] [Abstract][Full Text] [Related]
6. Arresting malaria parasite egress from infected red blood cells.
Lee MC; Fidock DA
Nat Chem Biol; 2008 Mar; 4(3):161-2. PubMed ID: 18277974
[No Abstract] [Full Text] [Related]
7. Home improvements: how the malaria parasite makes the red blood cell home sweet home.
Starnes GL; Waters AP
J Mol Cell Biol; 2010 Feb; 2(1):11-3. PubMed ID: 19805414
[TBL] [Abstract][Full Text] [Related]
8. High-resolution metabolomics to discover potential parasite-specific biomarkers in a Plasmodium falciparum erythrocytic stage culture system.
Park YH; Shi YP; Liang B; Medriano CA; Jeon YH; Torres E; Uppal K; Slutsker L; Jones DP
Malar J; 2015 Mar; 14():122. PubMed ID: 25889340
[TBL] [Abstract][Full Text] [Related]
9. Antimalarial drugs and drug targets specific to fatty acid metabolic pathway of Plasmodium falciparum.
Qidwai T; Khan F
Chem Biol Drug Des; 2012 Aug; 80(2):155-72. PubMed ID: 22487082
[TBL] [Abstract][Full Text] [Related]
10. Targeted repression of
Chakrabarti M; Garg S; Rajagopal A; Pati S; Singh S
Dis Model Mech; 2020 Jun; 13(6):. PubMed ID: 32493727
[TBL] [Abstract][Full Text] [Related]
11. Safety, tolerability, pharmacokinetics, and antimalarial efficacy of a novel Plasmodium falciparum ATP4 inhibitor SJ733: a first-in-human and induced blood-stage malaria phase 1a/b trial.
Gaur AH; McCarthy JS; Panetta JC; Dallas RH; Woodford J; Tang L; Smith AM; Stewart TB; Branum KC; Freeman BB; Patel ND; John E; Chalon S; Ost S; Heine RN; Richardson JL; Christensen R; Flynn PM; Van Gessel Y; Mitasev B; Möhrle JJ; Gusovsky F; Bebrevska L; Guy RK
Lancet Infect Dis; 2020 Aug; 20(8):964-975. PubMed ID: 32275867
[TBL] [Abstract][Full Text] [Related]
12. Identification of Antimalarial Compounds That Require CLAG3 for Their Uptake by
Mira-Martínez S; Pickford AK; Rovira-Graells N; Guetens P; Tintó-Font E; Cortés A; Rosanas-Urgell A
Antimicrob Agents Chemother; 2019 May; 63(5):. PubMed ID: 30782998
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial metabolism of sexual and asexual blood stages of the malaria parasite Plasmodium falciparum.
MacRae JI; Dixon MW; Dearnley MK; Chua HH; Chambers JM; Kenny S; Bottova I; Tilley L; McConville MJ
BMC Biol; 2013 Jun; 11():67. PubMed ID: 23763941
[TBL] [Abstract][Full Text] [Related]
14. Quantitative time-course profiling of parasite and host cell proteins in the human malaria parasite Plasmodium falciparum.
Foth BJ; Zhang N; Chaal BK; Sze SK; Preiser PR; Bozdech Z
Mol Cell Proteomics; 2011 Aug; 10(8):M110.006411. PubMed ID: 21558492
[TBL] [Abstract][Full Text] [Related]
15. A high-sensitivity HPLC assay for measuring intracellular Na(+) and K(+) and its application to Plasmodium falciparum infected erythrocytes.
Winterberg M; Kirk K
Sci Rep; 2016 Jul; 6():29241. PubMed ID: 27385291
[TBL] [Abstract][Full Text] [Related]
16. Global mass spectrometry based metabolomics profiling of erythrocytes infected with Plasmodium falciparum.
Sana TR; Gordon DB; Fischer SM; Tichy SE; Kitagawa N; Lai C; Gosnell WL; Chang SP
PLoS One; 2013; 8(4):e60840. PubMed ID: 23593322
[TBL] [Abstract][Full Text] [Related]
17. [Transport proteins as drug targets in Plasmodium falciparum. New perspectives in the treatment of malaria].
Ellekvist P; Colding H
Ugeskr Laeger; 2006 Mar; 168(13):1314-7. PubMed ID: 16579884
[TBL] [Abstract][Full Text] [Related]
18. Identification and functional analysis of the primary pantothenate transporter, PfPAT, of the human malaria parasite Plasmodium falciparum.
Augagneur Y; Jaubert L; Schiavoni M; Pachikara N; Garg A; Usmani-Brown S; Wesolowski D; Zeller S; Ghosal A; Cornillot E; Said HM; Kumar P; Altman S; Ben Mamoun C
J Biol Chem; 2013 Jul; 288(28):20558-67. PubMed ID: 23729665
[TBL] [Abstract][Full Text] [Related]
19. Treatment of erythrocytes with the 2-cys peroxiredoxin inhibitor, Conoidin A, prevents the growth of Plasmodium falciparum and enhances parasite sensitivity to chloroquine.
Brizuela M; Huang HM; Smith C; Burgio G; Foote SJ; McMorran BJ
PLoS One; 2014; 9(4):e92411. PubMed ID: 24699133
[TBL] [Abstract][Full Text] [Related]
20. A Novel Methodology for Bioenergetic Analysis of Plasmodium falciparum Reveals a Glucose-Regulated Metabolic Shift and Enables Mode of Action Analyses of Mitochondrial Inhibitors.
Sakata-Kato T; Wirth DF
ACS Infect Dis; 2016 Dec; 2(12):903-916. PubMed ID: 27718558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
